A Novel VIRTUAL Reality Intervention for CAREgivers of People With Dementia (VirtualCare)

NCT ID: NCT05780476

Last Updated: 2023-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-27

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial aims to explore if a virtual reality experience increases the beneficial effect of psychoeducational programs in informal caregivers of people with mild-to-moderate Alzheimer's disease. This study will test changes in psychological distress and neural activity in brain systems that regulate stress and empathic care.

Participants will be randomized into two arms: the control group will participate in an online psychoeducational intervention, while the experimental group will participate in the psychoeducational intervention combined with virtual reality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caregiver Burden

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two-arm randomized controlled design
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Psychoeducational program.

Group Type ACTIVE_COMPARATOR

Psychoeducation

Intervention Type BEHAVIORAL

6 sessions of 2 hours over 6 weeks

Experimental group

Psychoeducational program combined with virtual reality.

Group Type EXPERIMENTAL

Psychoeducation + virtual reality

Intervention Type BEHAVIORAL

6 sessions of 2 hours over 6 weeks. Virtual reality experience will be carry out in the last 30 minutes of each meeting. Virtual reality consists of 360-degree videos depicting everyday situations and allowing the caregivers to feel the specific symptoms of dementia (e.g., disorientation, agnosia, apraxia and memory loss).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychoeducation

6 sessions of 2 hours over 6 weeks

Intervention Type BEHAVIORAL

Psychoeducation + virtual reality

6 sessions of 2 hours over 6 weeks. Virtual reality experience will be carry out in the last 30 minutes of each meeting. Virtual reality consists of 360-degree videos depicting everyday situations and allowing the caregivers to feel the specific symptoms of dementia (e.g., disorientation, agnosia, apraxia and memory loss).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being an unpaid informal caregiver (CG; i.e., family members or friends) living with or caring for a person with Alzheimer's Disease (AD) for at least 4 hours a day for at least six months before enrolment;
* Caring for a person with a diagnosis of AD at prodromal or mild stage (i.e., Mini-Mental State Examination score:18-24) and still living at home.

Exclusion Criteria

* Receiving daily assistance for more than 10 hours from formal CGs;
* Being formal CGs (i.e., nurse or another paid figure);
* Being informal CGs of i) persons with moderate-to-severe AD, or ii) persons with non-AD diseases;
* Not having or being able to use a device connected to internet (e.g., smartphones or PC).
* Having received psychotherapeutic o psychological support, or having already participated to psychoeducational programs.
* Only a family member for person with dementia is accepted.


* Medical history of epilepsy.


* Metal implants, artificial prostheses, pace-makers, prosthetic heart valves;
* Claustrophobia;
* Pregnancy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alzheimer's Association

OTHER

Sponsor Role collaborator

University of Bergamo

OTHER

Sponsor Role collaborator

IRCCS Centro San Giovanni di Dio Fatebenefratelli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cristina Festari, PhD

Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cristina Festari, PhD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Brescia, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cristina Festari, PhD

Role: CONTACT

+39 030 3501335

Claudio Singh Solorzano, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cristina Festari, PhD

Role: primary

+39 030 3501335

References

Explore related publications, articles, or registry entries linked to this study.

Morganti F, Palena N, Savoldelli P, Greco A. Take the First-Person Perspective to Become Dementia-Friendly: The Use of 360 degrees Video for Experiencing Everyday-Life Challenges With Cognitive Decline. Front Psychol. 2020 Jun 30;11:1117. doi: 10.3389/fpsyg.2020.01117. eCollection 2020.

Reference Type BACKGROUND
PMID: 32695039 (View on PubMed)

Singh Solorzano C, Bonomini C, Rosini S, Passeggia I, Zanetti O, Pievani M, Frisoni GB, Festari C. The psychological impact of the disclosure of the diagnosis of Alzheimer's disease on informal caregivers. Alzheimers Dement. 2025 Sep;21(9):e70412. doi: 10.1002/alz.70412.

Reference Type DERIVED
PMID: 40908671 (View on PubMed)

Festari C, Bonomini C, Rosini S, Gattuso M, Singh Solorzano C, Zanetti O, Corbo D, Agnelli G, Quattrini G, Ferrari C, Gasparotti R, Pievani M, Morganti F. Virtual Reality Combined With Psychoeducation to Improve Emotional Well-Being in Informal Caregivers of Alzheimer's Disease Patients: Rationale and Study Design of a Randomized Controlled Trial. Int J Geriatr Psychiatry. 2024 Sep;39(9):e6145. doi: 10.1002/gps.6145.

Reference Type DERIVED
PMID: 39267224 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AACSF-22-924470

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.